Searchable abstracts of presentations at key conferences in endocrinology

ea0007p307 | Clinical practice | BES2004

Incidence and prevalence of thyroid dysfunction in the general population of Tayside, Scotland

Flynn R , MacDonald T , Morris A , Jung R , Leese G

Background: The objective of this study was to define the incidence and prevalence of treated thyroid dysfunction in a complete and representative population base.Method: We used record-linkage technology to retrospectively identify subjects treated for hyperthyroidism or hypothyroidism in the general population of Tayside, Scotland from 1 January 1993 to 30 April 1997. Thyroid status was ascertained by record-linkage of patient-level datasets containing...

ea0006oc25 | Neuroendocrinology | SFE2003

Sexual dimorphism in anterior pituitary function in the annexin 1 knockout mouse

John C , Morris J , Christian H , Flower R , Buckingham J

Immunoneutralisation and antisense studies have shown that the acute regulatory actions of glucocorticoids (GCs) on the secretion of corticotrophin (ACTH) from the anterior pituitary gland are dependent upon the 37 kDa protein, annexin 1 (Anxa1 [1]), which is localised mainly to the S100-positive folliculo-stellate (FS) cells that lie in close apposition with the endocrine cells. The aim of this study was to examine pituitary function in male and female mice lacking the Anxa1 ...

ea0006p65 | Steroids | SFE2003

Opposite effects of dexamethasone and oestardiol on annexin 1 expression

Solito E , Froud K , Christian H , Morris J , Buckingham J

Annexin 1 (ANXA1) is a Ca 2+ and phospholipid binding protein that plays an important role as a mediator of glucocorticoid (GC) action in the host-defence and neuroendocrine-systems. Our previous studies (Christian et al., 1998) in ovarietomised rats +/- oestradiol (E2) replacement suggested oestrogen may exert an inhibitory influence on ANXA1 expression in the pituitary gland. Our more recent finding that ANXA1 knockout mice exhibit unexpected sexual dimorphisms in...

ea0005oc28 | Brain and Behaviour | BES2003

Follistatin is secreted from pituitary folliculo-stellate cell lines by an ABCA1 transporter

Morris J , Kamitani T , Nishino S , Buckingham J , Christian H

The activin-binding protein follistatin is produced by folliculostellate (FS) cells of the anterior pituitary. FS cells make numerous contacts with the classical endocrine cells of the anterior pituitary including gonadotrophs. Follistatin released from the FS cells could therefore play a role in the regulation of gonadotrophin secretion, in particular of FSH. We have previously shown by confocal microscopy (1) that annexin 1, which is also produced by FS cells, is secreted fr...

ea0004oc17 | Steroid hormone action | SFE2002

Evidence from co-culture studies that annexin 1 serves as a paracrine mediator of glucocorticoid action between folliculo-stellate cells and corticotrophs

Tierney T , Christian H , Morris J , Buckingham J

Annexin 1 (ANXA1) plays an essential role in the 'early-delayed' feedback effects of glucocorticoids (GCs) on ACTH release. Evidence that ANXA1 is externalised from pituitary cells in response to GCs, together with the finding that the protein is localised mainly to the folliculo-stellate (FS) cells, has led us to propose that ANXA1 is a paracrine mediator of GC action in the anterior pituitary. To address this hypothesis we have examined ANXA1-dependent GC actions in co-cultu...

ea0004oc18 | Steroid hormone action | SFE2002

The role of phosphorylation in mediating the annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland

John C , Morris J , Flower R , Buckingham J

Our previous studies have shown that the acute regulatory actions of glucocorticoids (GCs) on the secretion of corticotrophin (ACTH) are dependent upon the translocation of a 37 kDa protein, annexin 1 (ANXA1 [1]) from within the cell to the outer cell surface where it is retained by a Ca2+-dependent mechanism (2). The mechanisms by which ANXA1 is exported from pituitary cells in response to a steroid challenge and acts on the endocrine cells to suppress peptide rele...

ea0004oc27 | Neuroendocrinology and diabetes | SFE2002

Co-localisation of ATP-binding cassette transporter 1 (ABCA1) and annexin I in folliculo-stellate cells

Christian H , Kamitani T , Nishino S , Buckingham J , Morris J

Annexin I, a phospholipid and calcium binding protein, plays a well demonstrated role in the early delayed inhibitory feedback actions of glucocorticoids in the pituitary. Annexin I is localized in folliculostellate (FS) cells and glucocorticoids act on these cells to externalize annexin I at specific foci on FS cell processes (Chapman et al, 2002 Endocrinology, in press). Annexin I lacks a signal sequence to direct it into the secretory pathway and the foci of externalized an...

ea0003oc45 | Neuroendocrinology | BES2002

Evidence for a role of the ATP-binding cassette transporter - A1 (ABC-A1) in the externalisation of annexin I from folliculostellate cells

Epton M , Chapman L , Morris J , Buckingham J , Christian H

Annexin I (ANXA1), a Ca2+- and phospholipid-binding protein is an important mediator of glucocorticoid (GC) action in the host defence and neuroendocrine systems. In the anterior pituitary ANXA1 is highly expressed by the folliculo-stellate (FS) cells (1). We have shown that GCs cause the externalization of annexin I in a FS cell line (murine TtT/GF) despite the fact that ANXA1 lacks a signal sequence and is not packaged in secretory granules. In bacteria and yeast ...

ea0003p105 | Diabetes & Metabolism | BES2002

Islet amyloid polypeptide (IAPP) accumulates in lysosomes of human beta-cells by crinophagy but does not form fibrils

Bhogal R , Novials A , Gomis R , Morris J , Clark A

Islet amyloid deposition is a characteristic feature of Type 2 diabetes. Accumulation of IAPP by abnormal intracellular peptide degradation in beta-cell could promote fibril formation. IAPP is present in high concentrations in beta-cell lysosomes. To determine if fibrils form in lysosomes and the pathway for the accumulation human islets were cultured under conditions of elevated production of insulin (11mM glucose) and inhibition of secretion (0.6mM diazoxide) and/or lysosoma...

ea0003p117 | Diabetes & Metabolism | BES2002

Ultrasound features of polycystic ovaries (PCO) and metabolic syndrome X

Atiomo W , Mikhalides D , Morris R , Hardiman P

Objective: To establish the prevalence of Syndrome X in women with Polycystic Ovary Syndrome (PCOS) and determine which sonographic features of PCO best predict syndrome X.Background: Recently, the third report of the USA national cholesterol education program expert-panel on the detection, evaluation and treatment of high blood cholesterol in adults specifically identified syndrome X, a combination of insulin resistance and compensatory hyperinsulinaemi...